# Escalated Therapy of Scabies With INFECTOSCAB 5% (Permethrin)

> **NCT04814511** · PHASE3 · UNKNOWN · sponsor: **Infectopharm Arzneimittel GmbH** · enrollment: 183 (estimated)

## Conditions studied

- Scabies

## Interventions

- **DRUG:** InfectoScab 5 % Creme
- **DRUG:** Permethrin 10 % Creme
- **DRUG:** Driponin 3 mg Tabletten

## Key facts

- **NCT ID:** NCT04814511
- **Lead sponsor:** Infectopharm Arzneimittel GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-11
- **Primary completion:** 2022-12
- **Final completion:** 2023-08
- **Target enrollment:** 183 (ESTIMATED)
- **Last updated:** 2021-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04814511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04814511, "Escalated Therapy of Scabies With INFECTOSCAB 5% (Permethrin)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04814511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*